» Articles » PMID: 35767151

Development and Application of Three-Dimensional Bioprinting Scaffold in the Repair of Spinal Cord Injury

Overview
Date 2022 Jun 29
PMID 35767151
Authors
Affiliations
Soon will be listed here.
Abstract

Spinal cord injury (SCI) is a disabling and destructive central nervous system injury that has not yet been successfully treated at this stage. Three-dimensional (3D) bioprinting has become a promising method to produce more biologically complex microstructures, which fabricate living neural constructs with anatomically accurate complex geometries and spatial distributions of neural stem cells, and this is critical in the treatment of SCI. With the development of 3D printing technology and the deepening of research, neural tissue engineering research using different printing methods, bio-inks, and cells to repair SCI has achieved certain results. Although satisfactory results have not yet been achieved, they have provided novel ideas for the clinical treatment of SCI. Considering the potential impact of 3D bioprinting technology on neural studies, this review focuses on 3D bioprinting methods widely used in SCI neural tissue engineering, and the latest technological applications of bioprinting of nerve tissues for the repair of SCI are discussed. In addition to introducing the recent progress, this work also describes the existing limitations and highlights emerging possibilities and future prospects in this field.

Citing Articles

3D digital light process bioprinting: Cutting-edge platforms for resolution of organ fabrication.

Jeong Y, Yoo J, Lee S, Kim M Mater Today Bio. 2024; 29:101284.

PMID: 39430572 PMC: 11490710. DOI: 10.1016/j.mtbio.2024.101284.


Innovative Strategies in 3D Bioprinting for Spinal Cord Injury Repair.

Kim D, Liu Y, Kim G, An S, Han I Int J Mol Sci. 2024; 25(17).

PMID: 39273538 PMC: 11395085. DOI: 10.3390/ijms25179592.


Molecular Mechanisms and Clinical Application of Multipotent Stem Cells for Spinal Cord Injury.

Szymoniuk M, Litak J, Sakwa L, Dryla A, Zezulinski W, Czyzewski W Cells. 2023; 12(1).

PMID: 36611914 PMC: 9818156. DOI: 10.3390/cells12010120.

References
1.
Groll J, Burdick J, Cho D, Derby B, Gelinsky M, Heilshorn S . A definition of bioinks and their distinction from biomaterial inks. Biofabrication. 2018; 11(1):013001. DOI: 10.1088/1758-5090/aaec52. View

2.
Savic G, DeVivo M, Frankel H, Jamous M, Soni B, Charlifue S . Long-term survival after traumatic spinal cord injury: a 70-year British study. Spinal Cord. 2017; 55(7):651-658. DOI: 10.1038/sc.2017.23. View

3.
Wong D, Leveque J, Brumblay H, Krebsbach P, Hollister S, LaMarca F . Macro-architectures in spinal cord scaffold implants influence regeneration. J Neurotrauma. 2008; 25(8):1027-37. PMC: 2946879. DOI: 10.1089/neu.2007.0473. View

4.
Zhang Q, Shi B, Ding J, Yan L, Thawani J, Fu C . Polymer scaffolds facilitate spinal cord injury repair. Acta Biomater. 2019; 88:57-77. DOI: 10.1016/j.actbio.2019.01.056. View

5.
Sandrow-Feinberg H, Houle J . Exercise after spinal cord injury as an agent for neuroprotection, regeneration and rehabilitation. Brain Res. 2015; 1619:12-21. PMC: 4540698. DOI: 10.1016/j.brainres.2015.03.052. View